<!doctype html>
<html lang="en">
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<title>FACS sorting of glioma initiating cells</title>
<meta name="Daniel Brown" content="a RNase protocol" />
<meta name="robots" content="index,follow" />
<link rel="stylesheet" type="text/css" href="plain.css"/>
<!--[if lte IE 7]>
<link rel="stylesheet" href="/scripts/layout/css/patches_3_3_1/patch_layout.css" />
<![endif]-->
<link href="http://www.embl.org/rss/embl_news.xml" type="application/rss+xml" rel="alternate" title="EMBL News" />
    </head>
    
<body>
<script type="text/javascript" src="130625_menuBar.js"> </script>

<h1>FACS sorting of glioma initiating cells</h1>
               
<h2>FACS Input sample sheet</h2>
		 <table border="1" cellpadding="10">
			<tr>
				<th>Sample</th>
				<th>Name + cell number</th>
				<th>Sample</th>
				<th>Name + cell number</th>
				<th>Sample</th>
				<th>Name + cell number</th>
			</tr>
			<tr>
				<td>1</td>
				<td> <form>Unstained: <input type="text" name="Unstained"></form> </td>
				<td>5</td>
				<td> <form>IgG1-APC (isotype): <input type="text" name="isotype"> </form> </td>
				<td>9</td>
				<td> <form>Sample 9: <input type="text" name="S9"> </form> </td>
			</tr>
			<tr>
				<td>2</td>
				<td> <form>PI only: <input type="text" name="PI"> </form> </td>
				<td>6</td>
				<td> <form>Sample 6: <input type="text" name="S6"> </form> </td>
				<td>10</td>
				<td> <form>Sample 10: <input type="text" name="S10"> </form> </td>
			</tr>
			<tr>
				<td>3</td>
				<td><form>CD44-FITC only: <input type="text" name="CD44"> </form> </td>
				<td>7</td>
				<td> <form>Sample 7: <input type="text" name="S7"> </form> </td>
				<td>11</td>
				<td> <form> Sample 11: <input type="text" name="S11"> </form> </td>
			</tr>
			</tr>
			<tr>
				<td>4</td>
				<td> <form>CD133-APC only: <input type="text" name="CD133"> </form> </td>
				<td>8</td>
				<td> <form>Sample 8: <input type="text" name="S8"> </form> </td>
				<td>12</td>
				<td> <form>Sample 12: <input type="text" name="S12"> </form> </td>
			</tr>
			</table>           

            
        <h2>Materials</h2>
<ul>
    <li>Complete media for sample collection</li>
    <li>FACS buffer. Store this buffer <b>cold</b></li>
    <ol>
    	<li>Dulbecco's PBS - 50mL</li>
    	<li>1% Fetal Calf Serum (FCS) - 500uL</li>
    	<li>2mM EDTA - 200uL of 0.5M</li>
    	<li>Propidium Iodide - add just before sort</li>
    </ol>
    <li>45uM cell strainer</li>
    <li>FACS tubes</li>
    <li>Accutase</li>
    <li>Wash buffer - DMEM/F12 + Pen/ Strep</li>
    <li>CD133-APC conjugate antibody (clone AC133 #130-098-829) </li>
    <li>CD44-FITC conjugate antibody (clone DB105 #130-098-210) </li>
    <li>Isotype control Keyhole limpet hemocyanin (not expressed in humans) BD Bio340442</li>
</ul>

<!--The protocol starts here-->
<h2>Procedure for neurosphere dissociation</h2>
<p>Work quickly and on ice to maximise viability.</p>
<ol>
    <li>Pipette cells in dishes into 50mL falcon tube. Rinse empty wells with some wash buffer and add to tube.</li>
    <li>Spin at 1000xg for 5 minutes in a centrifuge at room temp.</li>
    <li>Resuspend in 5mL wash buffer and spin again.</li>
    <li>Resuspend in 500uL - 3mL accutase as appropriate for cell number</li>
    <li>Incubate at <b>37 °C</b> for 2x 5 minutes, resuspending cells with a pipette in between.</li>
    <li>Dilute accutase with 4mL FACS buffer<b> (cold)</b>. Put through 45uM cell strainer into a fresh 50mL tube.</br>
    Pipette some FACS buffer first to wet the membrane. Transfer 5mL of cells to a FACS tube.</li>
    <li>Transfer approximately 10% <b>(500uL)</b> of this cell suspension to another FACS tube to be the isotype control.</li>
    <li>Take 50uL for a trypan blue count and record cell number on sample sheet.</li>
    <li>Remember to <b>replate</b> some cells (~100,000 cells/ well) into a 6 well plate.</li>
</ol>
    
<h2>Antibody labelling</h2>
<ol>
    <li>Spin down at 500xg at 4°C for 5 minutes.</li>
    <li>Resuspend in 90uL <i>for 100uL final vol</i>. 
    Add 5uL (1:21) CD133 antibody or isotype control, depending on the sample.</li>
    <li>Incubate for <b>20 minutes</b> in the dark in the fridge (dark).</li>
    <li>Wash with 1mL of FACS buffer and centrifuge for 500xg at 4°C for 5 minutes.</li>
    <li>Resuspend in a sufficient amount <b>minimum 500uL</b> of FACS buffer for FACS sorting. Aim for 5 - 10 million cells per mL.</li>
    <li>Before sorting add 1:100 of 1mg/mL (final 1ug/mL) PI to each tube. This is 5uL of Iwan's buffer for 500uL cells.</li>
</ol>

<!-- Make a page break -->
<page_break> </page_break>

<h2>FACS collection sample sheet</h2>
		 <table border="1" cellpadding="10">
			<tr>
				<th>Sample</th>
				<th>Name + cell number</th>
				<th>Sample</th>
				<th>Name + cell number</th>
				<th>Sample</th>
				<th>Name + cell number</th>
			</tr>
			<tr>
				<td>C_1</td>
				<td> <form>Name: <input type="text" name="Unstained"></form> </td>
				<td>C_5</td>
				<td> <form>Name: <input type="text" name="isotype"> </form> </td>
				<td>C_9</td>
				<td> Name: <input type="text" name="S9"> </form> </td>
			</tr>
			<tr>
				<td>C_2</td>
				<td> <form>Name: <input type="text" name="PI"> </form> </td>
				<td>C_6</td>
				<td> <form>Name: <input type="text" name="S6"> </form> </td>
				<td>C_10</td>
				<td> <form>Name: <input type="text" name="S10"> </form> </td>
			</tr>
			<tr>
				<td>C_3</td>
				<td><form>Name: <input type="text" name="CD44"> </form> </td>
				<td>C_7</td>
				<td> <form>Name: <input type="text" name="S7"> </form> </td>
				<td>C_11</td>
				<td> <form> Name: <input type="text" name="S11"> </form> </td>
			</tr>
			<tr>
				<td>C_4</td>
				<td> <form>Name: <input type="text" name="CD133"> </form> </td>
				<td>C_8</td>
				<td> <form>Name: <input type="text" name="S8"> </form> </td>
				<td>C_12</td>
				<td> <form>Name: <input type="text" name="S12"> </form> </td>
			</tr>
			</table>


<h2>FACS procedure 1 marker (CD133)</h2>
<p>The best results have been obtained by running an isotype control for each individual clone as their forward and side scatter are different.</p>
<ol>
	<li>Use the 100uM nozzle for less pressure through the sorter.</li>
	<li>Prepare two <small>(CD133pos and neg)</small> collection tubes filled with 1mL complete media per sample.</li>
	<li>Be sure to run the PI only, isotype control and CD133 positive control first.</li>
</ol>

<h2>FACS procedure 2 markers (CD133 and CD44)</h2>
<ol>
	<li>At step 10 of neurosphere dissociation add 5uL of CD133-APC and 5uL of CD44-FITC to samples</li>
	<li>Be sure to run the PI only, CD133-APC only and CD44-FITC only controls and ensure proper compensation.</li>
	<li>Ask if it valid to use a  Fluorescence Minus One (FMO) control for CD44. This will use the CD133, PI sample.</li>
	<li>Collect the 4 different populations {(CD133+, CD44+). (CD133+, CD44-), (CD133-, CD44+), (CD133-, CD44-)}.
	</ol>
	
<p>Fluorescence compensation is the mathematical subtraction of the fluorescence due to one fluorochrome from the fluorescence due to another fluorochrome. This is necessary because emission spectra from two fluorochromes can overlap.</p>

<h2>Limiting dilution sphere formation</h2>
  <p>From a protocol given by Fred Hollande from the <i>ELDA paper by Hu and Symth 2009</i>.</p>
  
  <ol>
    <li>Start with the limiting dilution first, then do the bulk collection</li>
    <li>Prepare 2x low attachment 96 well plates <b>(Labelled)</b> with 100uL of media</li>
    <li>The sorter can only dispense into one plate at a time</li>
    <li>Set the sorter to collect 1, 10, 100 and 1,000 cells in 24-plex ie 2 rows of the plate</li>
    <li>Incubate for 5 - 7 days and score for the presence or absence of spheres</li>
    <li>Determine neurosphere formation frequency using the ELDA web program from the WEHI bioinformatics website: <a href="http://bioinf.wehi.edu.au/software/elda/index.html">ELDA web program</a></li>
  </ol>
  
<h2>Temozolmide sensitivity assay</h2>
  <p>From a paper by Dagmar Beier <i>Efficacy of clinically relevant temozolomide dosing schemes in glioblastoma cancer stem cell lines</i> et al 2012; J Neurooncol.</p>
  
  <ol>
    <li>Plate 1,000 cells into each well of a 96 well plate.</li>
    <li>The next day after neurosphere formation add 50uM temozolomide.</li>
    <li>To the control (vehicle) wells add 0.2% v/v DMSO.</li>
    <li>This is the <b>important part of paper:</b> Replace half the media every day. Also replace the vehicle control. Do this for the 7 day on 7 day off protocol.</li>
    <li>Make a measurement of cell number by Resazurin, LDH, MTT after 7 or 14 days.</li>
  </ol>
  
<h3>Diluting temozolomide</h3>
<p>The stock concentration of drug is 25mM. The desired concentration of drug is 100uM in
50uL (for a final of 50uM in 100uL). Therefore it is 0.2uL of drug/ DMSO to 48.8uL media <b>per well</b>. This concentration corresponds to a physiological concentration of 200 mg/m^2 TMZ
</p>

<h6>Written by Daniel V Brown 03 June 2013</h6>
    </body>
</html>
